Covid-19
The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
4 Mar, 2021 | 08:59h | UTCAuthor Interview: Will COVID-19 Become a Recurrent Seasonal Disease? – JAMA
Systematic Review: Filtering Facepiece Respirator (N95 Respirator) Reprocessing
4 Mar, 2021 | 08:58h | UTCFiltering Facepiece Respirator (N95 Respirator) Reprocessing: A Systematic Review – JAMA
Commentary on Twitter
Reuse of N95 and related masks, a review of 42 studies https://t.co/PqnC5kzlrW
Comparison of merits of 5 different methods for retaining filtration https://t.co/PqnC5kzlrW@JAMA_current by @MSchumm90 and colleagues @UCLAHealth ? pic.twitter.com/Q6UMhhUhLy— Eric Topol (@EricTopol) March 3, 2021
Opinion | COVID vaccination studies: plan now to pool data, or be bogged down in confusion
4 Mar, 2021 | 08:48h | UTCCOVID vaccination studies: plan now to pool data, or be bogged down in confusion – Nature
A Review of Persistent Post-COVID Syndrome (PPCS)
4 Mar, 2021 | 08:45h | UTCA Review of Persistent Post-COVID Syndrome (PPCS) – Clinical Reviews in Allergy & Immunology
We still don’t know how well Covid vaccines stop transmission
4 Mar, 2021 | 08:46h | UTCWe Still Don’t Know How Well Covid Vaccines Stop Transmission – Wired
Commentary on Twitter
Do vaccines stop the coronavirus from spreading? Almost certainly! Do they block 89.4% of transmission? Probably not.
Here's what the new data out of Israel and the UK does (and doesn't) tell us about how to safely navigate a semi-vaccinated society:https://t.co/JZADHp3PrH
— Megan Molteni (@MeganMolteni) February 25, 2021
The myth of ‘good’ and ‘bad’ Covid vaccines: Why false perceptions overlook facts, and could breed resentment
4 Mar, 2021 | 08:44h | UTC
COVID-19 and healthcare workers: a rapid systematic review into risks and preventive measures
4 Mar, 2021 | 08:42h | UTC
Study: Smoking is associated with a higher risk of hospitalization and mortality from COVID-19 in a dose-dependent manner
4 Mar, 2021 | 08:41h | UTCCommentary: Heavy smokers have DOUBLE the risk of dying of COVID-19 – Daily Mail
NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms
3 Mar, 2021 | 08:55h | UTC
The vaccine race against the coronavirus variants, explained
3 Mar, 2021 | 08:52h | UTCThe vaccine race against the coronavirus variants, explained – Vox
WHO Guideline recommends against Hydroxychloroquine to prevent Covid-19
3 Mar, 2021 | 08:56h | UTCA living WHO guideline on drugs to prevent covid-19 – The BMJ
See also: WHO Living guideline: Drugs to prevent COVID-19 – World Health Organization
Commentaries: WHO advises against hydroxychloroquine to curb COVID-19 – CIDRAP AND WHO panel issues strong advice against hydroxychloroquine for COVID-19 – Reuters
Commentary on Twitter
The anti-inflammatory drug hydroxychloroquine should NOT be used to prevent infection in people who do not have #COVID19, according to the latest WHO clinical care guidance https://t.co/Oi2NJQMwiZ pic.twitter.com/0UQr78hNk4
— World Health Organization (WHO) (@WHO) March 2, 2021
COVID-19 research in critical care: the good, the bad, and the ugly
3 Mar, 2021 | 08:49h | UTCCOVID-19 research in critical care: the good, the bad, and the ugly – Intensive Care Medicine
Commentary on Twitter
Challenges, achievements, directions of critical care research in #pandemic, from early small #COVID19 studies (incomplete/inconsistent data), to large-scale registries, through overlapping/competing & underpowered trials, often with poor LMIC involvement.https://t.co/EyEui4pKPi pic.twitter.com/jUDXAVaD5z
— Intens Care Med (@yourICM) March 1, 2021
More transmissible and evasive SARS-CoV-2 variant growing rapidly in Brazil
3 Mar, 2021 | 08:53h | UTCOriginal study (preprint): Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil
Commentaries: Covid Brazil variant ‘may spread more easily’ – BBC AND Brazil coronavirus variant: what is it and why is it a concern? An expert explains – The Conversation
Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest
3 Mar, 2021 | 08:51h | UTC
Commentary on Twitter
Both the Pfizer BioNTech and the Oxford AstraZeneca vaccines are highly effective in reducing covid-19 infections and protecting against severe disease in older adults, preliminary data show https://t.co/THSv5kiIVt
— The BMJ (@bmj_latest) March 2, 2021
A Practical Guide for Anesthesia Providers on the Management of COVID-19 Patients in the Acute Care Hospital
3 Mar, 2021 | 08:48h | UTC
How to make ‘immunity passports’ more ethical
3 Mar, 2021 | 08:46h | UTCHow to Make ‘Immunity Passports’ More Ethical – Scientific American
Related: Twelve criteria for the development and use of COVID-19 vaccine passports
Clinical application of serologic testing for COVID-19 in contemporary cardiovascular practice
3 Mar, 2021 | 08:44h | UTC
Role of advanced imaging in COVID-19 cardiovascular complications
3 Mar, 2021 | 08:45h | UTCRole of advanced imaging in COVID-19 cardiovascular complications – Insights into Imaging
Another study shows higher antibody titer responses to a single dose of mRNA vaccine among patients with previous COVID-19 infection
2 Mar, 2021 | 02:13h | UTCRelated: Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection (studies and commentary)
WHO: Roadmap to improve and ensure good indoor ventilation in the context of COVID-19
2 Mar, 2021 | 02:15h | UTC
Commentary on Twitter
Wonderful guidance from @WHO on ventilation. Here are a couple of pages for non-residential settings. All the things we've been talking about: minimum 10 L/s/person, open doors & windows for cross-ventilation, use exhaust fans, filtration. https://t.co/umMzhiqKza pic.twitter.com/UEZLahi87v
— Linsey Marr (@linseymarr) March 1, 2021
Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children
2 Mar, 2021 | 02:11h | UTCAcute covid-19 and multisystem inflammatory syndrome in children – The BMJ
Commentary on Twitter
The most common symptoms in children with acute SARS-CoV-2 infection are fever and cough. This Clinical Update looks at the presentation of SARS-CoV-2 infection in children, transmission dynamics, and multisystem inflammatory disease @asicksamuelshttps://t.co/XrDtAhJUb9
— The BMJ (@bmj_latest) March 1, 2021
Studies: Secondary infections in patients with severe COVID-19
2 Mar, 2021 | 02:05h | UTCSecondary Infections in Patients with Severe COVID-19 – NEJM Journal Watch
Scaling up COVID-19 rapid antigen tests: promises and challenges
2 Mar, 2021 | 02:09h | UTCScaling up COVID-19 rapid antigen tests: promises and challenges – The Lancet Infectious Diseases
Review: Cardiovascular biomarkers in patients with COVID-19
2 Mar, 2021 | 02:07h | UTC
Commentary on Twitter
Cardiovascular #biomarkers in patients with #COVID19 – review article by @escardio Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association #ACVC_ESC https://t.co/9Mcx24fX8y#EHJACVC #cardiotwitter #medtwitter pic.twitter.com/y7kD2Oylrj
— European Society of Cardiology Journals (@ESC_Journals) March 1, 2021
Serious bradycardia and Remdesivir for COVID-19: a new safety concern
2 Mar, 2021 | 02:06h | UTC
Commentary on Twitter
⛔A new safety concern⛔
New ? post-marketing study @CMIJournal suggests that the use of remdesivir is significantly associated with an increased risk of reporting serious bradycardia compared with HCQ,LPV/RTV, tocilizumab or glucocorticoids #IDTwitter https://t.co/npLMchifEM— Antibiotic Steward? Bassam Ghanem (@ABsteward) February 27, 2021